
Lilly asks EU regulator to revisit Kisunla; CHMP recommends PTC's PKU drug
Plus, news about Merck, Vyne Therapeutics, Verastem Oncology, Oryzon Genomics, and Azitra:
Eli Lilly asks European regulator to reassess its Alzheimer’s drug: The European …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.